In Vivo Antibacterial Activity of MRX-I, a New OxazolidinoneLI, Cong-Ran; ZHAI, Qian-Qian; CHEN, Le-Tian et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 4, pp 2418-2421, issn 0066-4804, 4 p.Article

In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457HILLIARD, Jamese J; FERNANDEZ, Jeffrey; MELTON, John et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2028-2033, issn 0066-4804, 6 p.Article

New oxazolidinonesVARA PRASAD, J. V. N.Current opinion in microbiology. 2007, Vol 10, Num 5, pp 454-460, issn 1369-5274, 7 p.Article

Linezolid: a review of safety and tolerabilityVINH, Donald C; RUBINSTEIN, Ethan.The Journal of infection. 2009, Vol 59, issn 0163-4453, S59-S74, SUP1Article

Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionGUTSTEIN, D. E; KRISHNA, R; JOHNS, D et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 1, pp 109-122, issn 0009-9236, 14 p.Article

Anacetrapib: Hope for CETP Inhibitors?GURFINKEL, Ronen; JOY, Tisha R.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 5, pp 327-339, issn 1755-5914, 13 p.Article

In Vitro and In Vivo Activities of LCB01-0371, a New OxazolidinoneJEONG, Ji-Woong; JUNG, Sung-Ji; KWAK, Jin-Hwan et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5359-5362, issn 0066-4804, 4 p.Article

In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial AgentSCHAADT, Ronda; SWEENEY, Debora; SHINABARGER, Dean et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 8, pp 3236-3239, issn 0066-4804, 4 p.Article

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trialMORAN, Gregory J; FANG, Edward; COREY, G. Ralph et al.Lancet. Infectious diseases (print). 2014, Vol 14, Num 8, pp 696-705, issn 1473-3099, 10 p.Article

Early Experience with Tedizolid: Clinical Efficacy, Pharmacodynamics, and ResistanceRYBAK, Jeffrey M; MARX, Kayleigh; MARTIN, Craig A et al.Pharmacotherapy. 2014, Vol 34, Num 11, pp 1198-1208, issn 0277-0008, 11 p.Article

Action of Linezolid or Vancomycin on Biofilms in Ventriculoperitoneal Shunts In VitroBAYSTON, Roger; ULLAS, Gautham; ASHRAF, Waheed et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 2842-2845, issn 0066-4804, 4 p.Article

Novel desosamine-modified 14- and 15-membered macrolides without antibacterial activityPALEJ JAKOPOVIC, Ivana; BUKVIC KRAJACIC, Mirjana; MATANOVIC SKUGOR, Maja et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 10, pp 3527-3530, issn 0960-894X, 4 p.Article

Resistance to Linezolid Caused by Modifications at Its Binding Site on the RibosomeLONG, Katherine S; VESTER, Birte.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 603-612, issn 0066-4804, 10 p.Article

Use of linezolid in neonatal and pediatric inpatient facilities—results of a retrospective multicenter surveySIMON, A; MÜLLENBORN, E; DOHNA-SCHWAKE, C et al.European journal of clinical microbiology & infectious diseases (Print). 2012, Vol 31, Num 7, pp 1435-1442, issn 0934-9723, 8 p.Article

Inhibition of homodimerization of Toll-like receptor 4 by 4-oxo-4-(2-oxo-oxazolidin-3-yl)-but-2-enoic acid ethyl esterPARK, Se-Jeong; SEUNG HEE KANG; YOUNG KU KANG et al.International immunopharmacology (Print). 2011, Vol 11, Num 1, pp 19-22, issn 1567-5769, 4 p.Article

Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilizationMULANOVICH, Victor E; HUBAND, Michael D; MCCURDY, Sandra P et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 9, pp 2001-2004, issn 0305-7453, 4 p.Article

Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administrationHORCAJADA, Juan P; ATIENZA, Rebeka; SARASA, Maria et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 3, pp 550-552, issn 0305-7453, 3 p.Article

Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid ConsumptionSCHEETZ, Marc H; KNECHTEL, Stephanie A; MALCZYNSKI, Michael et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 6, pp 2256-2259, issn 0066-4804, 4 p.Article

SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitorsZHIJIAN LU; CHEN, Yi-Heng; LATHAM, Melanie J et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 1, pp 199-203, issn 0960-894X, 5 p.Article

A Rapid and Highly Diastereoselective Synthesis of Enantiomerically Pure (4R,5R)- and (4S,5S)-IsocytoxazoneBUCKLEY, Benjamin R; BULMAN PAGE, Philip C; MCKEE, Vickie et al.Synlett (Stuttgart). 2011, Num 10, pp 1399-1402, issn 0936-5214, 4 p.Article

Asymmetric Total Synthesis of the Caspase-1 Inhibitor (―)-Berkeleyamide AKULKARNI, Swapnil J; PEDDURI, Yakambram; CHITTIBOYINA, Amar G et al.Journal of organic chemistry. 2010, Vol 75, Num 9, pp 3113-3116, issn 0022-3263, 4 p.Article

Linezolid Penetration Into Cerebrospinal Fluid and Brain TissueTSONA, A; METALLIDIS, S; FOROGLOU, N et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 1, pp 17-19, issn 1120-009X, 3 p.Article

Linezolid in the Treatment of Multidrug-Resistant TuberculosisSCHECTER, G. F; SCOTT, C; TRUE, L et al.Clinical infectious diseases. 2010, Vol 50, Num 1, pp 49-55, issn 1058-4838, 7 p.Article

Ocular penetration of topically applied linezolid in a rabbit modelSALEH, Maher; JEHL, François; DORY, Anne et al.Journal of cataract and refractive surgery. 2010, Vol 36, Num 3, pp 488-492, issn 0886-3350, 5 p.Article

Potential Subtherapeutic Linezolid and Meropenem Antibiotic Concentrations in a Patient With Severe Burns and SepsisHALLAM, M.-J; ALLEN, J. M; JAMES, S. E et al.Journal of burn care & research. 2010, Vol 31, Num 1, pp 207-209, issn 1559-047X, 3 p.Article